Cargando…
Gycyrrhizic acid alleviates atherosclerotic lesions in rats with diabetes mellitus
Gycyrrhizic acid (GA), an inhibitor of high mobility group box 1 (HMGB1), inhibits inflammatory responses and is involved in the occurrence and development of several inflammation-related diseases. However, the role of GA in the atherosclerotic lesions caused by diabetes mellitus (DM) remains unknow...
Autores principales: | Zhao, Yaodong, Li, Wei, Zhang, Daimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436226/ https://www.ncbi.nlm.nih.gov/pubmed/34476498 http://dx.doi.org/10.3892/mmr.2021.12395 |
Ejemplares similares
-
Evaluation on curative effects of ethylene diamine tetra-acetic acid chelation therapy in treating with atherosclerotic cardiovascular disease: A protocol for systematic review and meta-analysis
por: Song, Tao, et al.
Publicado: (2020) -
Preventive Effect of Eucalyptol on the Formation of Aorta Lesions in the Diabetic-Atherosclerotic Rat
por: Mahdavifard, Sina, et al.
Publicado: (2021) -
Comparison of carotid and lower limb atherosclerotic lesions in both previously known and newly diagnosed type 2 diabetes mellitus
por: Li, Lian-Xi, et al.
Publicado: (2014) -
Tiaolipiwei Acupuncture Reduces Albuminuria by Alleviating Podocyte Lesions in a Rat Model of Diabetic Nephropathy
por: Zhang, Zhilong, et al.
Publicado: (2018) -
Dapagliflozin can alleviate renal fibrosis in rats with streptozotocin‑induced type 2 diabetes mellitus
por: Xue, Song, et al.
Publicado: (2023)